0001250853-20-000032.txt : 20200122
0001250853-20-000032.hdr.sgml : 20200122
20200122205451
ACCESSION NUMBER: 0001250853-20-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200117
FILED AS OF DATE: 20200122
DATE AS OF CHANGE: 20200122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McCracken Joseph S
CENTRAL INDEX KEY: 0001632454
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36225
FILM NUMBER: 20540145
MAIL ADDRESS:
STREET 1: C/O NEXVET BIOPHARMA PLC
STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK
STATE: L2
ZIP: 00000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kindred Biosciences, Inc.
CENTRAL INDEX KEY: 0001561743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461160142
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650-701-7901
MAIL ADDRESS:
STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2020-01-17
0
0001561743
Kindred Biosciences, Inc.
KIN
0001632454
McCracken Joseph S
1555 BAYSHORE HIGHWAY, SUITE 200
BURLINGAME
CA
94010
1
0
0
0
Stock Option (right to buy)
9.84
2020-01-17
4
A
0
48500
0
A
2030-01-16
Common Stock
48500
48500
D
The option will vest in four equal quarterly installments from the option grant date.
/s/ Joseph S. McCracken
2020-01-21